NCT06850727Phase 2Recruiting

Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis

Study sponsor: Odyssey Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-04Estimated
Enrollment · participants57Estimated
Source updated2026-02-11Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: Jan 2026. After: Apr 2026.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview